Koers Shandong Jincheng Pharmaceutical Group Co., Ltd
Aandelen
300233
CNE100001500
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15,66 CNY | +0,32% | +1,49% | -6,00% |
Omzet 2022 | 3,51 mld. 483 mln. 452 mln. | Omzet 2023 | 3,54 mld. 488 mln. 456 mln. | Marktkapitalisatie | 6,34 mld. 873 mln. 816 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 273 mln. 37,63 mln. 35,17 mln. | Nettowinst (verlies) 2023 | 175 mln. 24,12 mln. 22,54 mln. | EV/omzet 2022 | 2,43 x |
Nettoliquiditeiten 2022 | 208 mln. 28,7 mln. 26,82 mln. | Nettoliquiditeiten 2023 | 471 mln. 64,86 mln. 60,61 mln. | EV/omzet 2023 | 1,66 x |
K/w-verhouding 2022 |
32,1
x | K/w-verhouding 2023 |
37
x | Werknemers | 3.806 |
Dividendrendement 2022 |
0,66% | Dividendrendement 2023 |
1,2% | Vrij verhandelbaar | 69,23% |
1 dag | +0,32% | ||
1 week | +1,49% | ||
Lopende maand | -6,34% | ||
1 maand | -12,32% | ||
3 maanden | -6,23% | ||
6 maanden | -10,41% | ||
Lopend jaar | -6,00% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jia Quan Li
PSD | President | 52 | 01-02-08 |
Jing Liu
DFI | Director of Finance/CFO | 48 | - |
Geng Xiu Zheng
CTO | Chief Tech/Sci/R&D Officer | 60 | 01-01-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ye Qing Zhao
CHM | Chairman | 48 | 01-07-04 |
Jia Quan Li
PSD | President | 52 | 01-02-08 |
Xi Li Cui
BRD | Director/Board Member | 51 | 16-02-08 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 32 M€ | +4,15% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
14-06-24 | 15,66 | +0,32% | 3 361 800 |
13-06-24 | 15,61 | -1,70% | 3 923 540 |
12-06-24 | 15,88 | +1,53% | 5 298 800 |
11-06-24 | 15,64 | -0,13% | 4 340 400 |
07-06-24 | 15,66 | +1,49% | 4 467 900 |
slotkoers Shenzhen S.E., 14 juni 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-6,00% | 817 mln. | |
+51,12% | 795 mld. | |
+41,96% | 627 mld. | |
-7,32% | 350 mld. | |
+18,75% | 328 mld. | |
+8,73% | 294 mld. | |
+18,02% | 245 mld. | |
+1,27% | 222 mld. | |
+11,95% | 215 mld. | |
+3,72% | 160 mld. |